Post-infarct sleep disruption and its relation to cardiac remodeling in a rat model of myocardial infarction

被引:13
|
作者
Aghajani, Marjan [1 ]
Faghihi, Mahdieh [1 ]
Imani, Alireza [1 ,2 ]
Mahdavi, Mohammad Reza Vaez [3 ,4 ]
Shakoori, Abbas [5 ]
Rastegar, Tayebeh [6 ]
Parsa, Hoda [1 ]
Mehrabi, Saman [5 ]
Moradi, Fatemeh [1 ]
Moghaddam, Ehsan Kazemi [7 ,8 ]
机构
[1] Univ Tehran Med Sci, Physiol Dept, Fac Med, Tehran, Iran
[2] Univ Tehran Med Sci, Occupat Sleep Res Ctr, Tehran, Iran
[3] Shahed Univ, Tradit Med Clin Trial Res Ctr, Tehran, Iran
[4] Shahed Univ, Med Fac, Dept Physiol, Tehran, Iran
[5] Univ Tehran Med Sci, Fac Med, Genet Dept, Tehran, Iran
[6] Univ Tehran Med Sci, Fac Med, Anat Dept, Tehran, Iran
[7] Shiraz Univ Med Sci, Amir al Momenin Burn Hosp, Shiraz Burn & Wound Healing Res Ctr, Shiraz, Iran
[8] Shahed Univ, Med Fac, Dept Microbiol, Tehran, Iran
关键词
cardiac remodeling; myocardial infarction; nitric oxide; sleep restriction; ubiquitin-proteasome system; UBIQUITIN-PROTEASOME SYSTEM; REDUCES COMPENSATORY HYPERTROPHY; LEFT-VENTRICULAR PERFORMANCE; NF-KAPPA-B; OXIDATIVE STRESS; INJURY; OVEREXPRESSION; DEPRIVATION; DEGRADATION; EXPRESSION;
D O I
10.1080/07420528.2017.1281823
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Sleep disruption after myocardial infarction (MI) by affecting ubiquitin-proteasome system (UPS) is thought to contribute to myocardial remodeling and progressive worsening of cardiac function. The aim of current study was to test the hypothesis about the increased risk of developing heart failure due to experience of sleep restriction (SR) after MI. Male Wistar rats (n = 40) were randomly assigned to four experimental groups: (1) Sham, (2) MI, (3) MI and SR (MI + SR) (4) Sham and SR (Sham + SR). MI was induced by permanent ligation of left anterior descending coronary artery. Twenty-four hours after surgery, animals were subjected to chronic SR paradigm. Blood sampling was performed at days 1, 8 and 21 after MI for determination of serum levels of creatine kinase-MB (CK-MB), corticosterone, malondialdehyde (MDA) and nitric oxide (NO). Finally, at 21 days after MI, echocardiographic parameters and expression of MuRF1, MaFBx, A20, eNOS, iNOS and NF-kB in the heart were evaluated. We used H&E staining to detect myocardial hypertrophy. We found out that post infarct SR increased corticosterone levels. Our results highlighted deteriorating effects of post-MI SR on NO production, oxidative stress, and echocardiographic indexes (p < 0.05). Moreover, its detrimental effects on myocardial damage were confirmed by overexpression of MuRF1, MaFBx, iNOS and NF-kB (p < 0.001) in left ventricle and downregulation of A20 and eNOS (p < 0.05). Furthermore, histological examination revealed that experience of SR after MI increased myocardial diameter as compared to Sham subjects (p < 0.05). Our data suggest that SR after MI leads to an enlargement of the heart within 21 days, marked by an increase in oxidative stress and NO production as well as an imbalance in UPS that ultimately results in cardiac dysfunction and heart failure.
引用
收藏
页码:587 / 600
页数:14
相关论文
共 50 条
  • [1] Post-infarct cardiac remodeling predictions with machine learning
    Dieu, Xavier
    Chabrun, Floris
    Prunier, Fabrice
    Angoulvant, Denis
    Mewton, Nathan
    Roubille, Francois
    Reynier, Pascal
    Ferre, Marc
    Moal, Valerie
    Cottin, Laurane
    Furber, Alain
    Garcia, Gabriel
    Biere, Loic
    Mirebeau-Prunier, Delphine
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 355 : 1 - 4
  • [2] Resveratrol is equipotent to perindopril in attenuating post-infarct cardiac remodeling and contractile dysfunction in rats
    Raj, Pema
    Aloud, Basma Milad
    Louis, Xavier Lieben
    Yu, Liping
    Zieroth, Shelley
    Netticadan, Thomas
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2016, 28 : 155 - 163
  • [3] Strength training attenuates post-infarct cardiac dysfunction and remodeling
    Garza, Michael A.
    Wason, Emily A.
    Cruger, Justin R.
    Chung, Eunhee
    Zhang, John Q.
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2019, 69 (03) : 523 - 530
  • [4] Strength training attenuates post-infarct cardiac dysfunction and remodeling
    Michael A. Garza
    Emily A. Wason
    Justin R. Cruger
    Eunhee Chung
    John Q. Zhang
    The Journal of Physiological Sciences, 2019, 69 : 523 - 530
  • [5] A Novel Cardiac Muscle-Derived Extracellular Matrix Extract Reduces Dyskinesia and Post-Infarct Left Ventricular Remodeling in a Mouse Model of Myocardial Infarction
    O'Connor, Daniel M.
    Xu, Yaqin
    Smith, Robert S.
    Prasad, Konkal-Matt R.
    Ogle, Roy C.
    Hossack, John A.
    French, Brent A.
    CIRCULATION, 2011, 124 (21)
  • [6] Post-infarct morphine treatment reduces apoptosis and myofibroblast density in a rat model of cardiac ischemia-reperfusion
    Rajani, Sulail Fatima
    Faghihi, Mahdieh
    Imani, Alireza
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 887
  • [7] Voluntary exercise and cardiac remodeling in a myocardial infarction model
    Al Shahi, Hamad
    Kadoguchi, Tomoyasu
    Shimada, Kazunori
    Fukao, Kosuke
    Matsushita, Satoshi
    Aikawa, Tatsuro
    Ouchi, Shohei
    Shiozawa, Tomoyuki
    Takahashi, Shuhei
    Sato-Okabayashi, Yayoi
    Akita, Koji
    Isoda, Kikuo
    Miyazaki, Tetsuro
    Daida, Hiroyuki
    OPEN MEDICINE, 2020, 15 (01): : 545 - 555
  • [8] Post-infarct morphine treatment mitigates left ventricular remodeling and dysfunction in a rat model of ischemia-reperfusion
    Rajani, Sulail Fatima
    Imani, Alireza
    Faghihi, Mahdieh
    Izad, Maryam
    Kardar, Gholam Ali
    Salehi, Zahra
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 847 : 61 - 71
  • [9] Cardiovascular magnetic resonance assessment of myocardial infarction and post-infarct complications
    Assomull, R
    Cannell, TM
    Prasad, SK
    CORONARY ARTERY DISEASE, 2005, 16 (06) : 373 - 378
  • [10] Intermedin improves cardiac function and sympathetic neural remodeling in a rat model of post myocardial infarction heart failure
    Xu, Bin
    Xu, Hao
    Cao, Heng
    Liu, Xiaoxiao
    Qin, Chunhuan
    Zhao, Yanzhou
    Han, Xiaolin
    Li, Hongli
    MOLECULAR MEDICINE REPORTS, 2017, 16 (02) : 1723 - 1730